• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖酸锑钠组分的抗利什曼原虫活性。

Antileishmanial activity of sodium stibogluconate fractions.

作者信息

Roberts W L, Rainey P M

机构信息

Department of Laboratory Medicine, Yale University, New Haven, Connecticut 06510.

出版信息

Antimicrob Agents Chemother. 1993 Sep;37(9):1842-6. doi: 10.1128/AAC.37.9.1842.

DOI:10.1128/AAC.37.9.1842
PMID:8239593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC188079/
Abstract

Sodium stibogluconate, a pentavalent antimony derivative produced by the reaction of stibonic and gluconic acids, is the drug of choice for the treatment of leishmaniasis. It has been reported to be a complex mixture rather than a single compound. We separated sodium stibogluconate into 12 fractions by anion-exchange chromatography. One fraction accounted for virtually all the leishmanicidal activity of the fractionated material against Leishmania panamensis promastigotes, with a 50% inhibitory concentration (IC50) of 12 micrograms of Sb per ml; that of unfractionated sodium stibogluconate was 154 micrograms of Sb per ml. Further analysis of this active fraction revealed that a major component was m-chlorocresol, which had been included in the sodium stibogluconate formulation as a preservative. The IC50 of pure m-chlorocresol was 1.6 micrograms/ml, a concentration equivalent to that present in unfractionated sodium stibogluconate at a concentration of 160 micrograms of Sb per ml. After ether extraction to remove m-chlorocresol, the IC50 of sodium stibogluconate was > 4,000 micrograms of Sb per ml. In contrast, when L. panamensis amastigotes were grown in macrophages, the IC50 of ether-extracted sodium stibogluconate was 10.3 micrograms of Sb per ml. The 12 fractions of ether-extracted sodium stibogluconate obtained by anion-exchange chromatography had IC50s of 10.1 to 15.4 micrograms of Sb per ml. We conclude that preservative-free sodium stibogluconate has little activity against L. panamensis promastigotes but is highly active against L. panamensis amastigotes in macrophages. This activity is associated with multiple chemical species.

摘要

葡萄糖酸锑钠是由锑酸和葡萄糖酸反应生成的五价锑衍生物,是治疗利什曼病的首选药物。据报道,它是一种复杂混合物而非单一化合物。我们通过阴离子交换色谱法将葡萄糖酸锑钠分离成12个馏分。其中一个馏分几乎占了分级分离物质对巴拿马利什曼原虫前鞭毛体所有的杀利什曼活性,其50%抑制浓度(IC50)为每毫升12微克锑;未分级的葡萄糖酸锑钠的IC50为每毫升154微克锑。对该活性馏分的进一步分析表明,主要成分是间氯甲酚,它作为防腐剂包含在葡萄糖酸锑钠制剂中。纯间氯甲酚的IC50为1.6微克/毫升,该浓度相当于未分级的葡萄糖酸锑钠中每毫升含160微克锑时的浓度。用乙醚萃取以去除间氯甲酚后,葡萄糖酸锑钠的IC50大于每毫升4000微克锑。相比之下,当巴拿马利什曼原虫无鞭毛体在巨噬细胞中生长时,经乙醚萃取的葡萄糖酸锑钠的IC50为每毫升10.3微克锑。通过阴离子交换色谱法获得的经乙醚萃取的葡萄糖酸锑钠的12个馏分的IC50为每毫升10.1至15.4微克锑。我们得出结论,无防腐剂的葡萄糖酸锑钠对巴拿马利什曼原虫前鞭毛体几乎没有活性,但对巨噬细胞中的巴拿马利什曼原虫无鞭毛体具有高度活性。这种活性与多种化学物质有关。

相似文献

1
Antileishmanial activity of sodium stibogluconate fractions.葡萄糖酸锑钠组分的抗利什曼原虫活性。
Antimicrob Agents Chemother. 1993 Sep;37(9):1842-6. doi: 10.1128/AAC.37.9.1842.
2
Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.将婴儿利什曼原虫的无菌培养无鞭毛体用作体外模型,以研究五价锑的作用模式。
Antimicrob Agents Chemother. 1998 Dec;42(12):3097-102. doi: 10.1128/AAC.42.12.3097.
3
Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.喷他脒可诱导杜氏利什曼原虫前鞭毛体和体外培养的无鞭毛体对锑和防腐剂氯甲酚产生抗性。
Antimicrob Agents Chemother. 1997 May;41(5):1064-8. doi: 10.1128/AAC.41.5.1064.
4
In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.三价和五价锑制剂的体外抗利什曼原虫特性
Antimicrob Agents Chemother. 1995 Jun;39(6):1234-9. doi: 10.1128/AAC.39.6.1234.
5
Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.葡萄糖酸锑钠抗利什曼原虫活性的生化机制
Antimicrob Agents Chemother. 1985 Jun;27(6):916-20. doi: 10.1128/AAC.27.6.916.
6
Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.癸硫醇功能化的银纳米粒子是体外新的高效杀利什曼原虫药物。
World J Microbiol Biotechnol. 2018 Feb 19;34(3):38. doi: 10.1007/s11274-018-2420-0.
7
Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.杜氏利什曼原虫:维拉帕米对印度临床分离株前鞭毛体和无鞭毛体阶段体外对葡萄糖酸锑钠敏感性的影响
Exp Parasitol. 2006 Oct;114(2):103-8. doi: 10.1016/j.exppara.2006.02.015. Epub 2006 Apr 17.
8
In vitro efficacy of some drugs on promastigotes of Leishmania donovani.某些药物对杜氏利什曼原虫前鞭毛体的体外疗效。
Chemotherapy. 1977;23(4):267-75. doi: 10.1159/000221994.
9
In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells.体外检测利什曼原虫临床分离株的敏感性:前处理无鞭毛体可增强其对巨噬细胞宿主细胞的感染力。
Antimicrob Agents Chemother. 2009 Dec;53(12):5197-203. doi: 10.1128/AAC.00866-09. Epub 2009 Sep 14.
10
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.五价锑对杜氏利什曼原虫体外无鞭毛体的阶段特异性活性。
Antimicrob Agents Chemother. 1999 Feb;43(2):278-82. doi: 10.1128/AAC.43.2.278.

引用本文的文献

1
Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host.利什曼病化疗药物的最新进展:寄生虫细胞生物化学及其与宿主分子相互作用的重要性
Pathogens. 2023 May 12;12(5):706. doi: 10.3390/pathogens12050706.
2
Availability, Toxicology and Medical Significance of Antimony.锑的可用性、毒理学和医学意义。
Int J Environ Res Public Health. 2022 Apr 12;19(8):4669. doi: 10.3390/ijerph19084669.
3
Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to .皮肤利什曼病治疗无反应性的决定因素:聚焦于由……引起的人源性形式
Front Microbiol. 2021 Jun 1;12:638957. doi: 10.3389/fmicb.2021.638957. eCollection 2021.
4
Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice Liver.加速血液清除(ABC)现象有利于吐酒石在BALB/c小鼠肝脏中聚乙二醇化脂质体中的蓄积。
Patholog Res Int. 2018 Jan 16;2018:9076723. doi: 10.1155/2018/9076723. eCollection 2018.
5
Biophysical and Pharmacological Characterization of Energy-Dependent Efflux of Sb in Laboratory-Selected Resistant Strains of () Subgenus.(某)亚属实验室选择的抗性菌株中锑的能量依赖性外排的生物物理和药理学特征
Front Cell Dev Biol. 2017 Mar 24;5:24. doi: 10.3389/fcell.2017.00024. eCollection 2017.
6
In vitro antileishmanial activity of methanolic and aqueous extracts of Eucalyptus camaldulensis against Leishmania major.赤桉甲醇提取物和水提取物对硕大利什曼原虫的体外抗利什曼活性
J Parasit Dis. 2015 Mar;39(1):18-21. doi: 10.1007/s12639-013-0377-3. Epub 2013 Nov 12.
7
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.葡甲胺锑酸盐在健康和婴儿利什曼原虫(杜氏利什曼原虫)感染的BALB/c小鼠体内的生物分布。
Mem Inst Oswaldo Cruz. 2013 Aug;108(5):623-30. doi: 10.1590/0074-0276108052013014.
8
Antimony resistance in leishmania, focusing on experimental research.抗锑利什曼原虫,聚焦于实验研究。
J Trop Med. 2011;2011:695382. doi: 10.1155/2011/695382. Epub 2011 Nov 17.
9
Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophils.内源性 IL-13 在利什曼原虫感染期间肝脏肉芽肿成熟中发挥关键作用,与 IL-4Rα 反应性巨噬细胞和中性粒细胞无关。
J Infect Dis. 2011 Jul 1;204(1):36-43. doi: 10.1093/infdis/jir080.
10
In vitro and in vivo activity of Aloe vera leaf exudate in experimental visceral leishmaniasis.库拉索芦荟叶渗出物在实验性内脏利什曼病中的体外和体内活性
Parasitol Res. 2008 May;102(6):1235-42. doi: 10.1007/s00436-008-0899-2. Epub 2008 Feb 12.

本文引用的文献

1
EXPERIMENTS ON THE MECHANISM OF ACTION OF CHLOROCRESOL AND CAFFEINE.氯甲酚与咖啡因作用机制的实验
Br J Pharmacol Chemother. 1965 Apr;24(2):510-8. doi: 10.1111/j.1476-5381.1965.tb01740.x.
2
Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy.
Anal Biochem. 1993 May 15;211(1):1-6. doi: 10.1006/abio.1993.1223.
3
Human cutaneous lieshmania in a mouse macrophage line: propagation and isolation of intracellular parasites.人皮肤利什曼原虫在小鼠巨噬细胞系中的研究:细胞内寄生虫的增殖与分离
Science. 1980 Sep 12;209(4462):1240-42. doi: 10.1126/science.7403880.
4
The leishmaniases.
Prog Drug Res. 1974;18:289-351. doi: 10.1007/978-3-0348-7087-0_22.
5
Semiautomated assessment of in vitro activity of potential antileishmanial drugs.潜在抗利什曼原虫药物体外活性的半自动评估
Antimicrob Agents Chemother. 1985 Dec;28(6):723-6. doi: 10.1128/AAC.28.6.723.
6
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.使用葡萄糖酸锑钠或葡甲胺锑酸盐治疗内脏利什曼病期间锑的药代动力学。
Trans R Soc Trop Med Hyg. 1988;82(1):69-72.
7
Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).
Exp Parasitol. 1988 Oct;67(1):96-103. doi: 10.1016/0014-4894(88)90012-4.
8
Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.对五价锑治疗无反应患者的利什曼原虫属进行体外药物效力和药敏性定量评估。
Am J Trop Med Hyg. 1990 Nov;43(5):464-80. doi: 10.4269/ajtmh.1990.43.464.
9
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
N Engl J Med. 1990 Jan 4;322(1):16-21. doi: 10.1056/NEJM199001043220104.
10
Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture.
Mol Biochem Parasitol. 1991 Nov;49(1):111-8. doi: 10.1016/0166-6851(91)90134-r.